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Abstract
 
We recently described a novel way to isolate populations of antigen-reactive CD4
 
1
 
 T cells
with a wide range of reactivity to a specific antigen, using immunization with a fixed dose of
 
nominal antigen and FACS
 
®
 
 sorting by CD4
 
high
 
 expression. Phenotypic, FACS
 
®
 
, functional,
antibody inhibition, and major histocompatibility complex–peptide tetramer analyses, as well as
 
T cell receptor V
 
b
 
 sequence analyses, of the antigen-specific CD4
 
high
 
 T cell populations dem-
onstrated that a diverse sperm whale myoglobin 110–121–reactive CD4
 
1
 
 T cell repertoire was
activated at the beginning (day 3 after immunization) of the immune response. Within 6 d of
immunization, lower affinity clones were lost from the responding population, leaving an ex-
panded population of oligoclonal, intermediate affinity (and residual high affinity) T cells. This
T cell subset persisted for at least 4 wk after immunization and dominated the secondary im-
mune response. These data provide evidence that CD4
 
1
 
 T cell repertoire selection occurs early
in the immune response in vivo and suggest that persistence and expansion of a population of
oligoclonal, intermediate affinity T cells is involved in CD4
 
1
 
 T cell memory.
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Introduction
 
For over two decades a dominant approach to studying T
cell function has been derivation of T cell clones with
strong reactivity to a peptide antigen, followed either by
the production of T cell hybridomas or the construction of
TCR transgenic mice. These techniques employed a single
TCR and varied the dose of antigen to determine T cell
functional response. Further analyses of the dominant T
cell clones investigated the response of the clones to altered
peptide ligands, or suboptimal stimuli, applied in varying
doses (1–3). These studies produced a steady increase in our
knowledge of TCR-mediated cellular function. However,
missing from this approach was a clear delineation of how
the “dominant” TCR (used subsequently to make T cell
clones, T cell hybridomas, and TCR transgenes) emerged
from the preexisting T cell repertoire. It is now clear that a
single “dominant” clone can respond to many ligands in
addition to its natural ligand (4, 5), which implies that
many T cells should exist with the potential to react to any
given peptide antigen (6, 7). However, until recently there
has not been an effective way to study the emergence of
the dominant CD4
 
1
 
 T cell clone from the population of
potentially reactive CD4
 
1
 
 T cells. This was due in part to
the competitive technique for growing the dominant clone
in vitro, which eliminated the other T cells. In addition,
the study of T cell responses in vivo was hampered by the
low precursor frequency of antigen-specific CD4
 
1
 
 T cells
in the naive (unprimed) or even in the primed LNs (1/
50,000–300,000 in unprimed mice, 1/1,000–10,000 in
primed mice [8–11]). The study of the CD4
 
1
 
 T cell re-
sponse in vivo has mainly relied on adoptive transfer of T
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cell clones or studies using cells from TCR-transgenic mice
(12–15). However, all of the transferred T cells shared the
same TCR, thus no direct studies could be performed on
TCR repertoire development.
Recent work has begun to elucidate the development of
the CD4
 
1
 
 T cell repertoire in vivo. The combination of
flow cytometry and PCR-based amplification of particular
dominant TCR V genes has allowed the examination of
the development of an immune response in a nontrans-
genic animal (16–23), and PCR runoff assays have identi-
fied dominant T cell clonal expansions (24–27). The use of
multimeric peptide– MHC class II staining reagents (tet-
ramers) has produced new insights into CD4
 
1
 
 T cell re-
sponses in vivo (28–30). However, additional approaches
are needed to clarify the question of when and how a dom-
inant, restricted repertoire is selected during the CD4
 
1
 
 T
cell immune response.
Recently, we described a novel way to isolate the mu-
rine antigen-specific CD4
 
1
 
 T cell subpopulation, both in
vitro
 
 
 
and in vivo (31). We used the DBA/2 response to
the sperm whale myoglobin (SWM)
 
1 
 
peptide 110–121 to
show that, upon antigen challenge, CD4
 
1
 
 T cells upregu-
lated cell surface expression of CD4, and that the
 
 
 
CD4
 
high
 
subpopulation in vivo, which represented 
 
,
 
1% of the
CD4
 
1
 
 population, contained the entire population of anti-
gen-specific T cells (31). Subsequently, we have used the
CD4
 
high
 
 method to study antigen-specific immune re-
sponses in vivo to alloantigens (32) and autoantigens (33).
Earlier studies from our lab characterized the CD4
 
1
 
 T cell
response to SWM 110–121 in DBA/2 mice and had
shown utilization of a limited pool of TCR V
 
b
 
 chains
(34–38). The vast majority (
 
.
 
90%) of CD4
 
1
 
 T cell clones
and hybridomas derived from SWM 110–121 immune
DBA/2 mice used TCR V
 
b
 
8.2 with a canonical CDR3
consisting of the amino acid sequence (A/G)WDWx(x)
linked to the junctional region J
 
b
 
2.6 (38, 39). Here we
characterize the CD4
 
1
 
 T cell clonal selection process using
the CD4
 
high
 
 marker to isolate the entire SWM 110–121–
specific T cell population (not only the dominant respond-
ers) at sequential time points in vivo
 
 
 
after immunization,
assessing changes in the CD4
 
1
 
 T cell repertoire at each
time point. Our results suggest that a diverse antigen-spe-
cific CD4
 
1
 
 T cell response, using many V
 
b
 
 sequences and
including both high and low affinity cells, was present at
the beginning of the immune response (day 3 after immu-
nization), from which intermediate reactivity T cell subsets
with more homogenous V
 
b
 
8 usage expanded within 6 d
after immunization. Functional and phenotypic analyses of
these subsets suggested that peripheral selection was taking
place in the CD4
 
1
 
 T cell compartment very early in the
immune response, which resulted in the expansion of a
constricted, intermediate affinity antigen-specific T cell
repertoire.
 
Materials and Methods
 
Animals.
 
DBA/2 mice were purchased from The Jackson
Laboratory. Females from 8–12 wk of age were used in all exper-
iments.
 
Peptide.
 
SWM 110–121 (AIIHVLHSRHPG) was prepared
and HPLC purified at the Protein and Nucleic Acid Facility
(Beckman Center, Stanford University).
 
Antigen Proliferation Assays.
 
For proliferation assays with T
cell clones, 2.5
 
 
 
3 
 
10
 
4
 
 T cells were incubated in 96-well plates in
either T cell media alone or containing two- or fourfold dilutions
of SWM 110–121, ranging from 0.003 to 150 
 
m
 
M, and 5
 
 
 
3
 
 10
 
5
 
freshly irradiated syngeneic splenocytes. T cell medium consisted
of RPMI 1640 supplemented with 2 mM 
 
L
 
-glutamine, penicillin,
and streptomycin, nonessential amino acids, sodium pyruvate,
and 10 mM Hepes buffer (GIBCO BRL), 5 mM 2-ME (Sigma-
Aldrich), and 5% FCS. After 48 h at 37
 
8
 
C, 5% CO
 
2
 
, cells were
pulsed with 1 
 
m
 
Ci of [
 
3
 
H]thymidine and harvested 18 h later for
counting on a Beta plate (Wallac Inc.). Cell proliferation, as
counts per minute, was plotted against antigen concentration, and
ED
 
50 
 
values were derived by calculating the intercept of the anti-
gen concentration leading to half-maximal proliferation. In the
case of noncanonical T cell clones which did not reach a plateau
of proliferation at 150 
 
m
 
M of antigen, the lowest possible calcu-
lated ED
 
50
 
 was assigned and thus may be an underestimate. For
each T cell clone, a mean ED
 
50
 
 value was calculated from at least
two independent proliferation assays. To calculate the statistical
significance in ED
 
50
 
 value differences between both canonical and
noncanonical T cell populations at day 3 after primary immuniza-
tion, as well as between canonical T cell clones from day 6 after
primary and day 4 after secondary immunization, a two sample 
 
t
 
test, assuming unequal variances, was performed using Excel (Mi-
crosoft Corporation).
 
Ab Inhibition Assays.
 
For Ab inhibition assays with T cell
clones, 2.5
 
 
 
3
 
 10
 
4
 
 T cells were incubated in 96-well plates con-
taining 5
 
 
 
3
 
 10
 
5
 
 freshly irradiated syngeneic splenocytes, 30 
 
m
 
M
SWM 110–121, and twofold dilutions of anti-V
 
b
 
8 Ab (F23.1)
ranging from 0 to 2.5 
 
m
 
g/ml. The same medium was used as in
the proliferation assays. After 48 h at 37
 
8
 
C, 5% CO
 
2
 
, cells were
pulsed with 1 
 
m
 
Ci of [
 
3
 
H]thymidine and harvested 18 h later for
counting on a Beta plate (Wallac Inc.). The percentage of inhibi-
tion of proliferation was calculated for each dose of anti-V
 
b
 
8 Ab
as follows: {[proliferation (cpm) without any added anti-V
 
b
 
8
Ab]
 
 2 
 
[proliferation (cpm) with anti-V
 
b
 
8 Ab]}/[proliferation
(cpm) without any added anti-V
 
b
 
8 Ab].
 
FACS
 
®
 
 and Limiting Dilution Analysis.
 
Groups of two to
three mice were immunized at the base of the tail with 100 
 
m
 
g
SWM 110–121 in CFA. 3, 6, 8, 14, and 28 d later, draining in-
guinal LN cells were removed and single cell suspensions were
prepared. For studying the memory response, DBA/2 mice were
first immunized with 100 
 
m
 
g SWM in CFA at the base of the tail,
and 4 wk later, challenged through the same route with 100 
 
m
 
g
of the same peptide in IFA. 2, 4, 6, 9, and 14 d later, draining in-
guinal LN cells were removed and single cell suspensions were
prepared. The total number of LN cells was determined by
counting three times with a hemocytometer. 4 
 
3 
 
10
 
7
 
 cells were
stained for 20 min at 4
 
8
 
C with 10 
 
m
 
g PE-conjugated anti-CD4
Ab (Caltag) and with 10 
 
m
 
g FITC-conjugated anti-V
 
b
 
8 Ab
(F23.1; BD PharMingen) in FACS
 
®
 
 buffer (Dulbecco’s PBS with
2% FCS). The cells were analyzed by FACS
 
®
 
 and the highest 1%
of CD4
 
high
 
V
 
b
 
8
 
1
 
 
 
or CD4
 
high
 
V
 
b
 
8
 
2 
 
subsets were sterile sorted. Af-
ter sorting, small aliquots of positive and negative populations
were resuspended in FACS
 
®
 
 buffer and analyzed on the FACS
 
®
 
machine used for sorting to assess for percentage of purity of the
 
1
 
Abbreviations used in this paper: 
 
Bio, biotin; LDA, limiting dilution analy-
sis; PCC, pigeon cytochrome c; SWM, sperm whale myoglobin. 
1721
 
Fassò et al.
 
sorted populations. The cells were placed in limiting dilution cul-
ture at 96 replicates per dilution in microwells containing 5 
 
3
 
 10
 
5
 
irradiated DBA/2 spleen cells with 10 
 
m
 
M SWM and 10 U/ml
IL-2 final concentrations. After 10 d of incubation (378C, 5%
CO2), individual microcultures were resuspended and divided
equally into two new wells. Freshly irradiated DBA/2 spleen cells
(5 3 105/well) were then added either in the presence or absence
of 10 mM SWM without IL-2. Cultures were incubated 48 h
longer and pulsed with 1 mCi of [3H]thymidine during the last
18 h. Positive wells were defined as those exceeding the mean
cpm in the absence of antigen by 3 SD. The percentage of nega-
tive wells was plotted against cells per plate and analyzed by least-
squares linearization using Cricket Graph (Computer Associates,
Inc.). The exponential curve-fitting function produced an equa-
tion of the form: y 5 (v) 3 10(z)(x). v and z were derived from
the data, and the resultant precursor frequency (1/x) was calcu-
lated by setting y 5 0.37 according to Poisson statistics. The total
number of antigen-specific T cells present in the LN of each
mouse after each immunization (n) was calculated as follows: n 5
(z/100)/x, where z is the total number of cells present in the im-
munized LN and 1/x is the precursor frequency of SWM 110–
121–specific T cells in the CD4high population.
Limiting Dilution Analysis T Cell Clones. At selected time
points, duplicate plates were cultured at the time of restimulation;
one plate was maintained in culture while the other one was used
for proliferative response. Limiting dilution analysis (LDA) T cell
clones were subsequently grown from LDA plates which, accord-
ing to the Poisson statistical analysis, corresponded to #1 cell/
well. LDA T cell clones were restimulated every 10–14 d with
20 3 106 freshly irradiated DBA/2 spleen cells and 10 mM SWM
final concentration. LDA T cell clones were derived from three
independent immunizations.
TCR Vb PCR and Sequence Analysis. T cells were Ficoll pu-
rified 3 d after restimulation with SWM 110–121, and PolyA1–
mRNA was prepared using the Microfast Track™ method (In-
vitrogen). First-strand cDNA synthesis was performed on 2 mg
mRNA using an oligo (dT) primer (Promega) and moloney mu-
rine leukemia virus reverse transcriptase (GIBCO BRL/Life
Technologies). 4% of the reaction was used as a template for
PCR amplification. The 59 TCR Vb8 primer was 59-TAA GCG
GCC GCG AGG CTG CAG TCA-39 and the 39 Cb primer was
59-CAG CTC AGC TCC ACG TGG TC-39. The primer an-
nealing was performed at 558C for 1 min, the polymerase exten-
sion segment at 728C for 2 min, and the junctional region of the
Vb82-containing transcripts was amplified using these two prim-
ers in a thermal cycler (PerkinElmer) for 30 cycles. PCR products
were directly sequenced using the Thermo Sequenase radiola-
beled terminator cycle sequencing kit (Amersham Pharmacia
Biotech/Life Science Inc.) and displayed on a 6% acrylamide gel.
SWM 110–121–specific Soluble EaAb  MHC Class II–SWM
Tetramer Construction and Analysis.  PE-streptavidin–(IEAd
SWM)tetramer (PESA–[IEAdSWM]tetramer) was prepared as de-
scribed previously (36), with the following modifications.
The genes for IEa and IAbd were introduced into a single bac-
ulovirus. Sequences encoding the SWM peptide and a flexible
peptide linker were attached to the 59 end of the gene (40–42)
and a sequence encoding a linker and peptide substrate for bio-
tinylation was attached to the 39 end of the gene (28).
Soluble IEAdSWM–BirA was purified from culture superna-
tants of infected High 5 insect cells (Invitrogen) using mAb 14-4-4
immunoaffinity chromatography. IEAdSWM–BirA was eluted
with 50 mM NaCO3, pH 10.8, and neutralized with 0.88 M
Tris, pH 6.9. Pepstatin (0.7 mg/ml), leupeptin (1 mg/ml), PMSF
(0.1 mM), and SWM 110–121 peptide (0.34 mg/ml) were
added, and eluted protein was centricon-30 concentrated and ex-
changed into 50 mM bicine, pH 8.3, containing pepstatin, leu-
peptin, and PMSF. Purified IEAdSWM–BirA was biotinylated
with BirA enzyme (Avidity). 800 mg IEAdSWM–BirA at 1.6 mg/
ml was incubated with 12 mg BirA enzyme and 25 mg SWM
110–121 peptide in 50 mM bicine, pH 8.3, with 10 mM ATP,
10 mM magnesium acetate, and 40 mM biotin, pepstatin (0.7 mg/
ml), leupeptin (1 mg/ml), and PMSF (0.1 mM) overnight at
room temperature. To remove reactants and nonmonomeric
IEAdSWM–biotin (Bio), the reaction mixture was passed over a
Superdex 200HR10/30 size exclusion column (Amersham Phar-
macia Biotech) in PBS with 5 mM NaN3 (PBSA). Monomeric
IEAdSWM-Bio was pooled and concentrated, and pepstatin, leu-
peptin, and PMSF were added. The extent of biotinylation was
96%, as determined by ELISA (28).
PESA–(IEAdSWM)tetramer was formed by incubating 130 mg
IEAdSWM–Bio and 20 mg PESA (Rockland) in PBSA with pep-
statin, leupeptin, and PMSF on ice for 30 min. The mixture was
passed over a Superdex 200HR10/30 column to separate PESA–
(IEAdSWM)tetramer from monomeric IEAdSWM. Pepstatin, leu-
peptin, and PMSF were added to fractions. The PESA–(IEAd
SWM)tetramer peak was concentrated, and OD280 was determined.
We assume 1 OD280 5 1 mg/ml. The monomer peak was ana-
lyzed for percentage of biotinylation, and found to contain ample
biotinylated IEAdSWM. This finding indicated that the biotin-
binding sites on the tetramer were saturated.
2 3 105 clonal T cells or 105 hybridoma T cells in 30 ml CTM
(medium for T cells) were incubated with 20 ml of PESA–(IEAd
SWM)tetramer (diluted in T cell medium with 12.5 mM NaN3) at
50 mg/ml, for a final concentration of 20 mg/ml PESA–(IEAd
SWM)tetramer. Incubation was in 10% humidified CO2 at 378C.
CD4-Cychrome was added to the wells, and the plate was kept
for 20 min at 48C. Cells were washed three times before analysis
on an Epics XL flow cytometer (Beckman Coulter).
Results
Kinetics of the Antigen-specific CD41 T Cell Response to
SWM 110–121 In Vivo. At various time points after pri-
mary or secondary immunization with SWM 110–121,
LN cells from DBA/2 animals were harvested and stained
for CD4high and Vb8 expression. LDA established the pre-
cursor frequency of both CD4highVb81 and CD4highVb82
T cell populations at each selected time point. Data pre-
sented in Table I show the results of one of three or more
LDA experiments performed at each selected time point
for the CD4highVb81 population. The total number of an-
tigen-specific T cells present in the draining LN was esti-
mated from the calculated precursor frequencies and abso-
lute numbers of CD41 T cells in the LN preparation
(Table I). The results of repeated LDA experiments are
summarized in Fig. 1. These data demonstrate the relative
expansion of antigen-specific T cells during the course of
the primary and secondary immune response in both the
CD4highVb82 and CD4highVb81 populations. The antigen-
specific precursor frequency of the CD4highVb81 T cells at
day 3 after primary immunization (1/3,150) was near a
baseline level at 33 antigen-specific T cells in the immu-
nized LN (8–11). In the next 3 d, the number of antigen-1722 TCR-based Repertoire Selection during an Immune Response In Vivo
specific T cells in the CD4highVb81 population increased
rapidly to reach a maximum, at day 6, of .4,400
CD4highVb81 T cells in the draining LN, corresponding to
a 136-fold expansion in the number of antigen-specific
CD4highVb81 T cells from day 3 (Fig. 1). The number of
antigen-specific T cells decreased threefold by day 8, and
by day 28, only 5% of the peak antigen-specific CD41 T
cell number was still present (Fig. 1).
To delineate the CD41 T cell memory response, mice
were reimmunized 28 d after primary immunization and
the memory response was studied using CD4high T cells.
The baseline precursor frequency in the CD4highVb81 pop-
ulation immediately before secondary challenge was 6.6-
fold higher than the number of antigen-specific T cells
present at baseline, day 3 after primary immunization (Fig.
1). The CD41 T cell recall response reached its maximum
precursor frequency 4 d after secondary challenge, 2 d ear-
lier than in the primary response (Fig. 1). The total number
of antigen-specific CD41 T cells present at days 4 and 6 of
the memory response was not statistically different from
that seen at the peak of the primary response, and cor-
responded to a 24-fold expansion of the existing
CD4highVb81 T cells present 28 d after priming. Not only
was the memory response more rapid than the primary re-
sponse, but it was also more sustained after the peak of the
response was reached, taking longer for the number of
CD4highVb81 T cell precursors to fall to levels similar to
those seen after the primary response (Fig. 1).
The CD4highVb82 population kinetics were similar to
the CD4highVb81 kinetics, although the relative cell expan-
sions were less. There was a 13.5-fold expansion in anti-
gen-specific CD4highVb82 T cells between days 3 and 6 of
the primary response but, similar to the CD4highVb81 pop-
ulation, by 4 wk after primary immunization the precursor
frequency of antigen-specific T cells in the CD4highVb82
population decreased to 5.5% of the peak cell number (Fig.
1). The memory response in the CD4highVb82 population
was also more rapid and enhanced than the primary re-
sponse, with a 37.5-fold increase in the number of precur-
sors in the first 4 d after reimmunization and a peak which
was 2.5 times higher than the peak of the primary response
(Fig. 1). Data presented in Fig. 1 show the dominant ex-
pansion of the CD4highVb81 population compared with the
CD4highVb82 population. The presence of a significant an-
tigen-specific response in the Vb82 population of sorted
CD4high cells was surprising; previously, our lab had only
rarely been able to isolate SWM 110–121–reactive Vb82
CD41 T cells from bulk cultures in vitro (34–39).
The Antigen-specific CD4high T Cell Population Is Function-
ally Heterogeneous Early in the Immune Response but Rapidly
Evolves towards Functional Homogeneity. To test the hy-
pothesis that the responding T cell population differed at
day 3 and day 6 after priming, we produced a representa-
tive population of T cell clones at each time point by sort-
Table I.
Days after
immunization
Precursor
frequency
Number of
LN cells
Total number of
SWM-specific
Vb81 cells
1/x z 3 106 (z/100)/x
Primary 3 1/3,150 10.23 33
6 1/38 12.8 3,368
8 1/65 9.44 1,452
14 1/362 15.6 431
28 1/405 8.73 215
Secondary 2 1/217 23.55 1,085
4 1/37 20.95 5,662
6 1/42 20.00 4,762
8 1/76 12.65 1,665
14 1/125 10.35 828
Determination by LDA of antigen-specific precursor frequencies in
the CD4highVb81 population. The total number of antigen-specific
precursor cells present in the LNs during the primary and secondary
response to SWM 110–112 in the Vb81 population was derived from
the precursor frequency of antigen-specific T cells in the CD4highVb81
subset and from the total number of LN cells (z), using the equation
n 5 (z/100)/x. CD4highVb81 cells were sorted from primed LNs at days
3, 6, 8, 14, and 28 after primary immunization and days 2, 4, 6, 8, and
14 after secondary immunization. LDA was performed and the
precursor frequency (1/x) was derived by Poisson statistics as described
in Materials and Methods. Shown are the results of one representative
LDA experiment performed at each selected time point.
Figure 1. Kinetics of antigen-specific precursor frequencies during the
primary and secondary response in vivo. Mean fold expansion of antigen-
specific CD4high Vb81 and Vb82 T cells during the primary and memory
response to SWM 110–121, starting at day 3 after primary immunization
for the baseline precursor frequency. The total number of antigen-specific
T cells present at each given time point was determined by LDA as shown
in Table I and described in Materials and Methods. The mean total num-
ber of antigen-specific T cells used to determine the expansion of anti-
gen-specific T cells was the result of two or three independent LDA ex-
periments. The expansion was then calculated by dividing the mean total
number of antigen-specific T cells present on a given day by the number
of antigen-specific precursor cells present in day 3 cultures after primary
immunization.1723 Fassò et al.
ing CD4highVb81 T cells directly from LNs, performing
LDA, and selecting cells for expansion from plates with
precursor frequencies approximating one cell per well as
calculated by Poisson statistics. This approach avoided po-
tential tissue-culture artifacts due to competition for
growth between different clones in the same well. The
LDA T cell clones were tested for proliferative response.
The proliferative responses of the day 3 LDA-derived
clones, displayed in rank order, represented .3 logs of dis-
tribution in their ED50 values (Fig. 2 A). The ED50 values
were stable in repeated assays (SEM # 10%). The nature of
the rank order distribution of ED50 values in the day 6
group was more homogenous: most of the responses were
near a mean ED50 of 1 mM with a few outliers on each end
(Fig. 2 B). Most of the contraction of the immune response
was due to loss of high ED50 cells. This analysis of ED50 dis-
tribution raised the possibility that between days 3 and 6 af-
ter primary immunization, expansion of intermediate reac-
tivity antigen-specific CD41 T cells and loss of low
reactivity antigen-specific CD41 T cells had taken place.
TCR Sequence Analysis of the Antigen-specific TCR Reper-
toire during the Primary and Secondary Response. To deter-
mine whether clonal expansion occurred between days 3
and 6 of the primary response (as suggested by the emer-
gence of a dominant ED50 value in the population; Fig. 2),
we sequenced the junctional regions of the TCR Vb
chains of the Vb81 LDA clones. Almost half of the Vb81
LDA clones (42.6%) isolated at day 3 displayed “noncanon-
ical” CDR3 junctional regions (Fig. 3 A). However, in
agreement with previous studies from our lab, data pre-
sented in Fig. 3 B demonstrate that the majority (87.7%) of
LDA clones found at the peak of the primary immune re-
sponse (day 6) displayed the previously described canonical
CDR3, consisting of the amino acid sequence (A/G)
WDWx(x) linked to the junctional region Jb2.6 (32, 33;
Fig. 3 B). Within the canonical group, 53.1% of the LDA
clones displayed the identical specific clonotype AWD-
WGS (Fig. 3 B). The “memory” T cell clones found 4 wk
after primary immunization, but before restimulation, dis-
played a majority (86.4%) of canonical CDR3 regions;
however, no preference for a specific clonotype was found
(Fig. 3 C). In contrast, at the peak of the recall response
(4 d after restimulation with antigen in vivo) not only did
the majority (82.7%, 43/52) of the LDA clones examined
contain canonical CDR3 regions, but an obvious prefer-
ence for the specific clonotype Vb8.2-AWDWES-Jb2.6
(59.6%, 31/52) was also found (Fig. 3 D). In summary, af-
ter day 6 of the primary response, no further shift in T cell
repertoire towards T cells expressing the canonical TCR
was observed; the canonical/noncanonical TCR ratio was
the same at days 6, 28, and 32 (4 d after repriming; Fig 3,
A–D).
Functional Analysis of the Antigen-specific CD4high T Cell
Population Directly Correlated TCR Sequence with TCR Reac-
tivity. As the amino acid composition of the CDR3 loop
of most canonical LDA clones isolated at day 6 was similar
to the canonical clones seen at day 3 (Fig. 3, A and B), we
asked whether a functional difference between canonical
and noncanonical LDA T cell clones was responsible for
the expansion of clones containing the canonical CDR3
region observed between days 3 and 6 of the primary im-
mune response. Our lab has shown that avidity differences
in TCR–antigen–MHC interactions lead to shifts in ED50
values (the antigen dose required to reach half-maximal
proliferation), with lower avidities leading to higher ED50
values and vice versa (1). In these experiments, antigen
dose and the affinity of the peptide for the MHC were
constants, and the TCR density was comparable on sam-
pled T cell clones by FACS® analysis (data not shown).
Therefore, the system described here could be used to pro-
vide information about the reactivity of the TCR of the T
cell clones for the antigenic ligand SWM 110–121 by mea-
suring their ED50 values in a proliferation assay.
44 LDA clones from day 3 cultures and 44 LDA clones
from day 6 cultures were tested for proliferation in re-
sponse to SWM 110–121 to determine their ED50 values
compared with their TCR sequences (Table II). Generally,
T cell clones with low ED50 values (,2 mM) contained the
canonical CDR3 region, whereas T cell clones displaying
high ED50 values (.10 mM) always expressed a noncanon-
ical CDR3 region. In LDA clones from day 3 cultures, the
mean ED50 value for all T cell clones with the canonical
Figure 2. Distribution of ED50
values in CD4high LDA T cell clones.
CD4highVb81  cells sorted from
primed LNs 3 and 6 d after primary
immunization were expanded from
limiting dilution cultures. For each
selected time point, T cell clones
were derived from three indepen-
dent immunizations. (A) 44 LDA
clones derived from day 3 and (B) 44
LDA clones derived from day 6 cul-
tures after primary immunization
were tested for proliferative re-
sponse, and the mean ED50 values
were plotted in rank order. Each
LDA clone was tested at least twice
(SEM # 10%) in order to determine
a mean ED50 (as described in Materi-
als and Methods).1724 TCR-based Repertoire Selection during an Immune Response In Vivo
TCR (n 5 27/44) was 24-fold lower than in the nonca-
nonical group (P , 0.0036; Table II). In LDA clones from
day 6 cultures, the mean ED50 value for all LDA clones dis-
playing the canonical TCR (n 5 40/44) was nine times
lower than the group displaying the noncanonical TCRs
(Table II). We next examined the ED50 values of LDA
clones expressing the canonical TCR, derived 4 d after sec-
ondary immunization, to determine whether a further ma-
jor shift in ED50 values occurred in the memory response.
The mean ED50 of sampled LDA clones expressing the ca-
nonical TCR sequence obtained at the peak of the second-
ary response was statistically indistinguishable from that
Figure 3. TCR Vb CDR3 sequence analysis of CD4high LDA T cell
clones. CD4highVb81 cells sorted from the primed LNs at days 3, 6, and
28 after primary immunization and at day 4 after secondary immuniza-
tion with SWM 110–121 were expanded from limiting dilution cultures.
For each selected time point, T cell clones were derived from three inde-
pendent immunizations. TCR Vb CDR3 sequence analysis was per-
formed on (A) 47 LDA clones from day 3, (B) 49 LDA clones from day
6, (C) 22 LDA clones from day 28 after primary immunization, and (D)
52 LDA clones from day 4 after secondary immunization. Each clone was
tested for antigen specificity in a proliferation assay (Fig. 4, and data not
shown). The alignment is based on common use of the Vb8 segment.
Boxes separate germline sequences from N-region additions. Each TCR Db and Jb assignment is displayed next to the corresponding sequence. The
predicted amino acid sequence is displayed below each corresponding sequence. Sequences which contain the CDR3 amino acid composition (A/
G)WDWx(x) (in bold) are listed as canonical; the other sequences are considered noncanonical. The numbers of clones displaying a particular clono-
typic sequence as well as percentages of canonical and noncanonical sequences are listed. *No assignment to either a Db1 or a Db2 germline sequence
could be made.1725 Fassò et al.
seen in the “canonical group” of day 6 LDA clones, ob-
tained after primary immunization (0.86 and 0.36 mM
[P 5 0.96]).
To correlate the ED50 value with the reactivity of the
TCR for the antigenic ligand, it was necessary to demon-
strate that the observed ED50 values resulted from a TCR
signal. Comparable expression of major costimulatory mol-
ecules including CD28, B7-1, B7-2, and CD4, on T cell
clones displaying higher and lower ED50 values could be
seen by FACS® analysis (data not shown). In addition, a
more direct assay was performed to demonstrate the role of
the TCR in determining the proliferative capacity of the
clones. Titrated doses of anti-Vb8 Abs were used in Ab in-
hibition assays to inhibit the proliferative response of the T
cell clones (which all used the Vb8 TCR). Ab inhibition
experiments were performed on Vb81 T cell clones dis-
playing different ED50 values (over a range of 2 logs; 0.07–
60 mM). Data presented in Fig. 4 A show inhibition curves
for representative T cell clones, all with different ED50 val-
ues. At a fixed dose of SWM 110–121, a lower ED50 value
of the T cell clone necessitated a higher Ab dose to reach
the same threshold of inhibition (Fig. 4 A). Data presented
in Fig. 4 B show the results of Ab inhibition assays for all T
cell clones tested. A linear inverse correlation was found
between the ED50 value of a T cell clone and the percent-
age of inhibition of the proliferative response. T cell clones
displaying low ED50 values were inhibited less at a given
dose of Ab than T cell clones displaying a higher ED50 (Fig.
4 B). Furthermore, inhibition curves of T cell clones dis-
playing comparable ED50 values were superimposable in
this inhibition assay. These results demonstrated that the
distribution in ED50 values observed in the LDA T cell
clone population resulted from an effect mediated by the
TCR. In other words, the measured ED50 values were a di-
rect result of the reactivity of a particular TCR for its
ligand, as TCR density, antigen dose, and affinity of pep-
tide for the MHC were kept constant.
The results from proliferation assays, TCR Vb sequence
analysis, and TCR-specific Ab inhibition curves all sug-
gested that the ED50 as measured by thymidine incorpora-
tion correlated with TCR affinity to MHC–peptide. To
formally demonstrate this, we developed an MHC–SWM
110–121 tetramer reagent, whose binding has been shown
Table II.
Number
of clones Mean ED50 6 SE
3 d after primary
immunization*
Canonical 27/44 (61.4%) 0.74 6 0.15
Noncanonical 17/44 (38.6%) 19.11 6 5.4 (P , 0.0036)
6 d after primary
immunization‡
Canonical 40/44 (91.0%) 0.97 6 0.15
Noncanonical 4/44 (9.0%) 8.4 6 7.2
*Statistical analysis of ED50 values in Vb81 T cell clones from day 3 af-
ter primary immunization. 27 T cell clones containing the canonical
CDR3 region consisting of the amino acid sequence (A/G)WDWx(x)
and 17 T cell clones expressing a noncanonical CDR3 region were
tested for proliferation in order to determine their ED50 value (antigen
concentration leading to half-maximal proliferation). Each clone was
tested at least twice. A mean ED50 value was calculated for each single
clone (the SEM were 10%). The mean ED50 values shown in the table
represent the mean of all T cell clones in each group. Statistical analysis
was performed as described in Materials and Methods.
‡Statistical analysis of ED50 values in Vb81 T cell clones from day 6 af-
ter primary immunization. 40 T cell clones containing the canonical
CDR3 region and 4 T cell clones expressing a noncanonical CDR3 re-
gion were tested for proliferation in order to determine their ED50 val-
ues (as described above).
Figure 4. Direct correlation between TCR function and ED50 values.
(A) Inhibition of proliferation in response to 30 mM SWM 110–121 by
titrated doses of anti-Vb8 Ab. Inhibition curves for four representative T
cell clones are shown. The mean ED50 value of each respective T cell
clone is 3D3 (ED50 $ 50 mM), 3B5b (ED50 5 15 mM), 3E11 (ED50 5
0.6 mM), and 3E4 (ED50 5 0.07 mM). (B) Shown is the correlation be-
tween the ED50 values of nine T cell clones and the percentage of inhibi-
tion of proliferative response to 30 mM SWM 110–121 when 1.25 mg/ml
anti-Vb8 Ab was added to the culture. At ED50 5 1 mM and ED50 5 50
mM, three different T cell clones displaying identical ED50 were tested to
determine the percentage of inhibition of proliferation. Each T cell clone
was tested at least twice. Error bars represent the SEM.1726 TCR-based Repertoire Selection during an Immune Response In Vivo
to be directly proportional to biochemical affinity (29).
Representative clones were assayed for tetramer binding
compared with a panel of control (known) TCRs with es-
tablished affinity, as well as to the previously generated
SWM-reactive T cell hybridoma 11.3.7 (Fig. 5 A). The
TCR dissociation constants (KD) were estimated for the
SWM-reactive clones from these data (Fig. 5 A). The order
of the estimated KD correlated precisely with the ED50, as
measured by proliferation assays (Fig. 5 B). Notably, several
noncanonical clones were below the limit of detection of
the tetramer system despite having a measurable prolifera-
tive response to the SWM peptide. Previous studies in one
of our labs had also demonstrated that low affinity/high
ED50 T cell clones (reactive to the 3K peptide) failed to
stain with their specific tetramer reagent despite producing
IL-2 in response to the peptide (29). Using MHC-trans-
fected L cells, we demonstrated that these low affinity,
non–tetramer-binding SWM-reactive clones were re-
stricted by the I-AaEb restriction element, just as were the
high affinity clones (data not shown). In addition, all clones
were tested and shown to respond against whole SWM to
prove that peptide reactivity corresponded to true SWM
reactivity for each clone (data not shown). Collectively, the
results demonstrated that ED50 was a reliable indicator of
TCR affinity for MHC–SWM 110–121 in our system.
Discussion
The results presented here demonstrate that TCR-based
selection in the peripheral CD41 T cell compartment oc-
curred early during an antigen-specific immune response in
vivo. We determined the kinetics of the primary and sec-
ondary T cell immune response to SWM 110–121 in vivo,
examining both the CD4highVb81 and CD4highVb82 popu-
lations, by performing LDA on the CD4high population of
primed LN cells using our recent finding that, upon anti-
gen challenge, antigen-specific T cells upregulate cell sur-
face expression of CD4 (30–33). As expected from our pre-
vious studies, a dominant SWM 110–121–specific response
was observed in the CD4highVb81 T cell population. A
rapid increase in antigen-specific T cell precursor fre-
quency was seen between days 3 and 6 of the primary im-
mune response (Fig. 1). Within 2 wk of primary immuni-
zation, only 5% of the peak precursor number was present;
however, this represented a 6.6-fold higher baseline pre-
cursor frequency of CD4highVb81 T cells at day 28 com-
pared with day 3 (Table I). The secondary response in both
the Vb81 and Vb82 populations was more rapid and more
sustained than the primary response (Fig. 1). The CD4high
approach revealed the expected dominant antigen-specific
Vb81 T cell population, but also demonstrated a Vb82 an-
tigen-specific T cell population reactive to SWM 110–121.
This was surprising, as our lab and others (using T cell
clones and hybridomas) had only rarely isolated Vb82
SWM 110–121–specific T cells from bulk cultures (34–39).
Combined with our previous studies, these data suggest
that SWM 110–121–specific Vb82 T cells cannot readily
expand in bulk culture when Vb81 SWM 110–121–spe-
cific T cells (derived from a primary immunization) are
present, consistent with the observation that the degree of
heterogeneity in long term T cell lines is less than in freshly
obtained LN cells, indicating that a selection process occurs
in vitro (43).
Although the total number of antigen-specific T cells in
the CD4highVb82 and CD4highVb81 populations in vivo
was comparable during the primary and secondary re-
sponse, the kinetics demonstrate the dominant expansion
of the Vb81 subset (Fig. 1). The dominance of the Vb81 T
Figure 5. Correlation between tetramer staining
and TCR affinity.  (A) SWM 110–121–specific
MHC–SWM tetramers constructed as described in
reference 36 and Materials and Methods were used
to stain representative SWM reactive T cell clones.
The corrected mean fluorescence intensity was nor-
malized to the level of staining with a biotinylated
anti-Cb mAb detected with PESA. The normal-
ized staining was used to estimate the KD of each
clone TCR from a previously constructed standard
(references 28 and 42) curve relating staining inten-
sity to known TCR KD (reference 28). (B) Correla-
tion between estimated KD and ED50. The clones
are the same as used for tetramer analysis in A.1727 Fassò et al.
cells was not due to the fact that Vb81 SWM-reactive T
cells outnumbered the Vb82 cells at the onset of the im-
mune response, as the number of total antigen-specific pre-
cursors (as determined by day 3 LDA) was 2.7-fold higher
in the CD4highVb82 population than the CD4highVb81
population (Fig. 1). However, selection of Vb81 SWM-
reactive T cells occurred rapidly and by day 6, 3.7 times
fewer Vb82 than Vb81 cells were present. Between days 3
and 6 of the primary immune response, we observed a 136-
fold expansion in the number of antigen-specific T cells in
the CD4highVb81 subset compared with only a 13.5-fold
expansion in the CD4highVb82 T cells subset (Fig. 1).
Therefore, our data suggest that in vivo, SWM 110–121–
specific Vb81 T cells have a selective advantage compared
with SWM 110–121–specific Vb82 T cells.
We have presented four lines of evidence that support
the idea that clonal maturation of the peripheral T cell rep-
ertoire occurs early during the immune response in vivo,
and reflects a process of TCR-based selection of the anti-
gen-specific T cells. First, as opposed to the continuous dis-
tribution in ED50 values of LDA T cell clones isolated at
day 3 (which reflected the heterogeneous nature of the
population of T cells seen after the primary immunization;
Fig. 2 A), the majority of the Vb81 LDA clones from day 6
displayed similar ED50 values, with only a few outliers on
each side (Fig. 2 B), suggesting that a selection for Vb81
LDA clones had taken place in vivo. Second, TCR se-
quence analysis performed on LDA clones derived from
days 3, 6, and 28 of the primary response, and day 4 of the
secondary response, indicated a strong bias towards select-
ing T cells containing the canonical amino acid composi-
tion (A/G)WDWx(x) in their CDR3. Third, our ED50
analysis showed that the skewing towards a “canonical”
TCR sequence in the population correlated with a selec-
tion of T cells that displayed lower ED50 values (higher re-
activity), i.e., a functional change in the T cell repertoire
correlated precisely with a TCR structural change (Table
II). Fourth, MHC–peptide tetramer analysis of the clones
demonstrated a precise correlation between ED50 and TCR
affinity (KD; Fig. 5), suggesting that selection was based on
both sequence and affinity of the TCR Vb CDR3 region.
Our data demonstrate that TCR-based repertoire selec-
tion for CD41 T cells with an intermediate affinity for an-
tigen takes place at the beginning of the primary immune
response. TCR repertoire selection occurring in the CD41
T cell repertoire during the first 6 d of a primary immune
response is difficult to demonstrate, primarily due to lack of
technical means for tracking a wide population of different
antigen-specific CD41 T cells at early time points after pri-
mary immunization. TCR repertoire maturation (i.e., nar-
rowing in T cell repertoire) has been shown recently using
different antigen immunization models to occur after sec-
ondary antigenic challenge (18–20, 44). In their pigeon cy-
tochrome c (PCC) immunization model, McHeyzer-Wil-
liams et al. demonstrated that the CD41 T cell secondary
(memory) response to PCC was more homogeneous than
the primary response in terms of CDR3 loop length and
amino acid composition (18–20, 45). The overall kinetics
of dominant expansion shown here are similar to those
demonstrated in the PCC system (18, 19). However, in
our system, the TCR repertoire at the peak of the memory
response was not demonstrably more homogeneous than
that seen at the peak of the primary immune response. The
only time we observed a major change in the proportion of
“canonical” to “noncanonical” TCRs was at the beginning
of the primary response (from days 3 to 6); the second
McHeyzer-Williams study saw a similar early expansion of
antigen-specific cells, although they reported a further nar-
rowing in the secondary response in their PCC system
(20). For at least 4 wk after primary immunization, we saw
no changes in the percentage of canonical to noncanonical
TCR expression, and the same canonical TCR seen at the
peak of primary response was used at the peak of the mem-
ory response.
Anti-TCR Ab inhibition and MHC–SWM 110–121
tetramer assays demonstrated that the measured ED50 val-
ues, in this system, were directly controlled by the TCR of
the T cell clones. This result is in agreement with results
from several groups, which showed (using surface plasmon
resonance to measure affinity) that the main signal event in
T cell activation occurs through TCR engagement, and
that there exists an extremely good correlation between the
duration (half-life) of the TCR interaction with the ligand,
peptide–MHC complex, and the biological (i.e., prolifera-
tive) response of the T cell (46–50). Of additional interest is
our finding that low-affinity T cell clones can be undetect-
able by a tetramer-based detection system (Fig. 5), which
has also been reported using other CD41 T cell–tetramer
systems (29). This points to inherent limits in the assays
currently used to detect “antigen-specific” CD41 T cells.
Functional assays (such as those based on proliferation) may
not detect all reactive cells (e.g., TCR-mediated cytokine
stimulation in absence of cell cycling could be overlooked),
whereas tetramer reagents may not bind TCRs of lower af-
finity. Both methods would then systematically underesti-
mate precursor frequency. In this study, we found compa-
rable expression of major costimulatory molecules (CD28,
B7-1, B7-2, and CD4) among T cell clones displaying
higher and lower ED50 values. Although adhesion mole-
cules are important in bringing cells together for TCR en-
gagement to occur (51, 52), they are not central to the sig-
naling event (53, 54). Therefore, we conclude that in our
experiments, the observed T cell proliferative response was
a direct reflection of the TCR reactivity for its ligand. Our
analysis showed that the ED50 values we found for memory
phase–derived T cell clones expressing canonical CDR3
regions were indistinguishable from those of canonical
LDA clones isolated on day 6 after primary immunization.
These data suggest that the more rapid and enhanced mem-
ory response was not due to the ability of memory T cells
to proliferate more efficiently upon encounter with the an-
tigen (as they displayed ED50 values in vitro comparable to
primary LDA clones), but to the elevated precursor fre-
quency present at the end of the primary response.
Our results clearly demonstrate that a TCR repertoire
selection process occurred early in the immune response in1728 TCR-based Repertoire Selection during an Immune Response In Vivo
vivo, resulting in a relatively homogenous population of
CD41 T cells with a TCR-determined intermediate reac-
tivity to antigen. The results of the MHC–SWM tetramer
analysis suggest that the TCR-based, TCR sequence–
dependent, intermediate reactivity demonstrated here
should be referred to as “TCR affinity” (and hence the se-
lection process demonstrated here described as “affinity se-
lection”), although this is currently a matter of controversy,
as both kinetics and affinities of TCR interactions are cru-
cial in determining the biological reactivity of a T cell (30,
49, 55). The direct effect of the different TCR sequences
on the function of T cells involved in the early immune re-
sponse demonstrated here may also be mediated by the ef-
fect of TCR structure on the kinetics (half-life and off-rate)
of the TCR–peptide interaction, and hence reflect “kinetic
selection” mediated by the TCR, as recently reported by
Savage et al. (30). This group showed that memory and
primary T cell populations responsive to PCC differed in
their binding kinetics to peptide–MHC tetramers, suggest-
ing a kinetic basis for the TCR repertoire maturation ob-
served previously (18–20, 30). Our results differ from stud-
ies by both Savage et al. in a CD41 system and Busch et al.
in a CD81 system in that we did not see a narrowing of the
range of response after secondary antigen challenge (30,
55). Furthermore, we saw a similar average antigen reactiv-
ity of the T cells in our secondary immune response: in our
results, the same canonical sequence and ED50 values dom-
inated at the peak of the primary and secondary responses.
Other antigen–MHC–TCR systems should be studied
in the future by multiple approaches to clarify which sys-
tem shows “typical” immune repertoire selection behavior
in vivo. However, regardless of whether the TCR-based
selection of the CD41 T cell repertoire response to antigen
challenge is due to TCR-based kinetics or TCR-based af-
finity, the process demonstrated here clearly fulfills the cri-
teria of what Burnett envisioned as clonal selection in the
CD41 T cell compartment (56).
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